Board of Directors
Mike Cordonnier is the Co-Founder, President and Chief Executive Officer at Carlsmed, and serves as the Chair of the Board of Directors.
With more than two decades of leadership experience introducing groundbreaking medical technologies, Mike has guided teams across both private and public organizations, including NuVasive, Ellipse Technologies, Zimmer Biomet, Orchid Orthopedics, and X-Spine Systems.
He holds a Bachelor of Science degree in Mechanical Engineering from the University of Dayton.
Kevin is the Lead Independent Director and serves as Chair of the Compensation Committee, as well as a member of the Audit and Nominating & Corporate Governance Committees on the Carlsmed Board of Directors.
He is currently a board member at Intrinsic Therapeutics, Miach Orthopedics, Razor Medical, FzioMed, Shoulder Innovations, and Moximed. He previously served on the Board of Rotation Medical, Ceterix, and Pivot Medical.
Kevin is the former CEO of St. Francis Medical Technologies and Moximed, and formerly served as Worldwide President of Johnson & Jonhnson's DePuy Orthopedics.
He earned a Bachelor of Science in Accounting from West Virginia University.
Kevin O'Boyle serves as Chair of the Audit Committee and is a member of the Compensation Committee on the Carlsmed Board of Directors. He currently serves on the board of Nevro (NVRO) and has previously served as a director of seven publicly traded companies, including Wright Medical Group (WMGI), GenMark Diagnostics (GNMK), and Zeltiq (ZLTQ).
Kevin is a former Senior Vice President and CFO of Advanced BioHealing and CFO of NuVasive, as well as CFO and COO of ChromaVision Medical Systems, and CFO and SVP of Operations at Albert Fisher Group PLC.
He holds a Bachelor of Science in Accounting from the Rochester Institute of Technology and completed the Executive Program at UCLA Anderson School of Management.
Dr. Jonathan Root serves as Chair of the Nominating and Corporate Governance Committee on the Carlsmed Board of Directors.
He is a General Partner at U.S. Venture Partners and currently serves on the boards of Edgewise Therapeutics, Inari Medical, Silverback Therapeutics, Cleave Therapeutics, HealthJoy, Okami Medical, Omada Health, nuvaira, Ribon Therapeutics, Route 92 Medical, and Sparrow Pharmaceuticals.
Previously, he served on the boards of eFFECTOR Therapeutics, Lutonix, Microvention, OncoMed Pharmaceuticals, Sequent Medical, and Proteolix.
Prior to joining U.S. Venture Partners, Dr. Root was an Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Special Care Unit at Cornell Medical Center.
He earned his M.D. from the University of Florida College of Medicine, an M.B.A. from Columbia University, and an A.B. in Economics from Dartmouth College
Dr. Robert Mittendorf serves as a member of the Compensation Committee and the Nominating and Corporate Governance Committee on the Carlsmed Board of Directors.
He is a General Partner and Head of Healthcare at B Capital where he leads venture and growth investments across the sector. His team has led investments in Hotspot Therapeutics, Lively, Aetion, Oncomyx, and triumvira OR, where he also serves as Board Director or Observer.
Dr. Mittendorf previously held leadership or board roles with companies including Impel NeuroPharma, Silk Road Medical, TigerConnect, Avalyn Pharma, Neocis, Telcare, VisitPay, IntersectENT, iRhythm, Omada, Talkspace, and iCardiac.
Before his venture capital career, Dr. Mittendorf led Marketing and Business Development at Hansen Medical.
He earned an M.D. from Harvard University, an M.B.A. from Harvard Business School, an M.S. in Systems Engineering from MIT, and an M.A. in International Relations from King's College London.
Phil Young serves as a member of the Audit Committee on the Carlsmed Board of Directors.
He is a Senior Advisor at U.S. Venture Partners, following two decades as a Managing General Partner. Phil has served on numerous boards, including Aerogen, Aptus Endosystems, CardioThoracic Systems, CardioVascular Imaging Systems, CoCensys, Compugen, Dotomi, rеdox, HeartFlow, La Jolla Pharmaceuticals, Penederm, 3Dfx Interactive, RelayHealth, SentreHEART, Simpirica Spine, Synarc, St. Francis Medical Technologies, The Immune Response Corporation, Vical, Xoma, and Zoran.
Earlier in his career, he was President and CEO of Oximetrix and served on the Board of Trustees of Cornell University, where he chaired eCornell for nearly 20 years.
Phil earned an M.B.A. from Harvard Business School, an M.S. in Engineering Physics from George Washington University, and a B.M.E. from Cornell University.
Niall Casey is the Co-founder and Chief Intellectual Property Officer at Carlsmed and serves on the Board of Directors
A seasoned professional in the spine industry, Niall brings deep expertise from technology leadership roles at Alphatec Spine, Ellipse Technologies, NuVasive, and Johnson & Johnson DePuy Synthes Spine.
He holds a J.D. from Suffolk University, and M.S. and B.S. degrees in Biomedical Engineering from Case Western Reserve University.
Company Officers
Mike Cordonnier is the Co-Founder, President and Chief Executive Officer at Carlsmed, and serves as the Chair of the Board of Directors.
With more than two decades of leadership experience introducing groundbreaking medical technologies, Mike has guided teams across both private and public organizations, including NuVasive, Ellipse Technologies, Zimmer Biomet, Orchid Orthopedics, and X-Spine Systems.
He holds a Bachelor of Science degree in Mechanical Engineering from the University of Dayton.
Leo is the Chief Financial Officer of Carlsmed, bringing more than two decades of strategic financial leadership across the surgical device, biotechnology, and oncology diagnostics sectors.
Prior to joining Carlsmed, he served as CFO of Tarsus Pharmaceuticals, Inc., where he helped guide the company through significant growth and value-creating milestones, including its IPO in October 2020.
He holds a J.D. from Temple University’s Beasley School of Law and a B.A. in Accounting from Arcadia University. Leo is also a Certified Public Accountant and a member of the California State Bar, uniquely blending financial, legal, and operational expertise to support Carlsmed’s mission and long-term success.
Jennifer is the Chief Legal Officer at Carlsmed and serves as Secretary of the Carlsmed Board of Directors.
She brings extensive legal expertise to Carlsmed, with a proven record of advising public life sciences and technology companies on complex corporate and regulatory matters. Prior to joining Carlsmed, she served as the Chief Legal Officer of Akoya Biosciences and held senior legal roles at Rubius Therapeutics and Progress Software Corporation.
Jennifer began her legal career at Skadden, Arps, Slate, Meagher & Flom LLP, representing biotechnology, pharmaceutical, and technology clients in the areas of mergers and acquisitions, securities law and corporate governance. She holds a J.D. from Northeastern University School of Law and a B.A. in History from UCLA.
Scott is the Chief Commercial Officer at Carlsmed.
With more than 30 years of experience in the medical device industry, Scott has held leadership roles across sales, marketing, and corporate strategy. His career includes successful tenures at U.S. Surgical Corporation, Boston Scientific Corporation, and NuVasive.
Scott holds a Bachelor of Business Administration in Marketing from the University of Kentucky.
Sharon is the Chief Clinical & Market Access Officer at Carlsmed.
Sharon’s extensive professional journey includes senior leadership roles in marketing and surgical affairs at prominent companies such as J&J and Stryker. She has also played crucial C-suite roles at successful startup ventures, namely Micropore Biosurgery, N-Spine, and Tissue Regeneration Systems, all of which achieved successful exits.
Sharon holds a Bachelor of Science degree in Medical Technology from Loyola University Maryland.
Shariq is the Chief Technology Officer at Carlsmed.
He has a strong track record of entrepreneurship and execution in technology and executive leadership roles at MedTech companies Intelliguard Solutions and Safety Syringes.
Shariq holds an MBA in Technology Management from National University, a B.S. in Computer Science and Engineering from UC San Diego, and another B.S. in Information Technology from National University.
Niall Casey is the Co-Founder and Chief Intellectual Property Officer at Carlsmed and serves on the Board of Directors.
A seasoned professional in the spine industry, Niall brings deep expertise from technology leadership roles at Alphatec Spine, Ellipse Technologies, NuVasive, and Johnson & Johnson DePuy Synthes Spine.
He holds a J.D. from Suffolk University, and M.S. and B.S. degrees in Biomedical Engineering from Case Western Reserve University.